Diabetes patients on colchicine after PCI show lower in-stent restenosis rates

04/29/2013 | Healio

Data on 196 diabetes patients who underwent percutaneous coronary intervention with a bare-metal stent showed those who received colchicine had an in-stent restenosis rate of 16%, compared with 33% in the placebo group. Colchicine-treated patients also had lower rates of late lumen loss than those in the control group, researchers wrote in the Journal of the American College of Cardiology.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC